Cutler Group LLC / CA - SEELOS THERAPEUTICS INC ownership

SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 84 filers reported holding SEELOS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of SEELOS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0417
-59.0%
0.00%
Q2 2023$01,0170.0%0.00%
Q1 2023$0
-100.0%
1,017
-53.8%
0.00%
Q4 2022$1
-100.0%
2,200
-50.1%
0.00%
Q3 2022$4,0000.0%4,410
-91.8%
0.00%
Q2 2022$4,000
-55.6%
54,000
-1.6%
0.00%
Q1 2022$9,000
-74.3%
54,900
+6.6%
0.00%
-100.0%
Q4 2021$35,000
-34.0%
51,500
-60.1%
0.00%
-50.0%
Q3 2021$53,000
+5200.0%
129,000
+1128.6%
0.00%
Q2 2021$1,000
-97.1%
10,500
-28.6%
0.00%
-100.0%
Q1 2021$34,00014,7000.00%
Other shareholders
SEELOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,500,000$4,075,0001.71%
Connacht Asset Management LP 498,925$813,0000.79%
GENDELL JEFFREY L 2,449,267$3,992,0000.32%
MANGROVE PARTNERS IM, LLC 2,133,436$3,478,0000.21%
Uniplan Investment Counsel, Inc. 1,550,359$2,527,0000.14%
Financial Advocates Investment Management 24,673$1,994,0000.13%
Connacht Asset Management LP 72,300$118,0000.12%
Woodline Partners LP 4,047,231$6,597,0000.09%
1492 Capital Management LLC 108,286$177,0000.09%
Ikarian Capital, LLC 244,171$398,0000.06%
View complete list of SEELOS THERAPEUTICS INC shareholders